Another point associated with deals in China.
This current deal seems to be focused entirely on Fokangren and Evolis products alone.
http://www.cellmid.com.au/SiteMedia...01 Chinese Import Permits Received FINAL.pdf
This occurred last year with the Lexilis and Joju products and shipments resumed.
Resumed to whom?
Huana Likang would be my bet.
And didn't the CEO recently say that China sales were improving?
Given the time it took for CDY to get the permits renewed for Lexilis, CDY have taken a different approach by getting the Chinese Company to obtain the permits from the inside, so to speak, which they claim as one of their leading benefits. As the Lexilis permits run out in 2021 perhaps CDY ought to get cracking on the next lot or perhaps get Huana Likang to do a bit of spadework to assist.
The way I see it is we have two lots of product in a pincer movement.
Evolis is to attack the upmarket end of things and pharmacies while Lexilis plugs away with established deals and a possible QVC deal with online shopping.
"And never the twain shall meet"
Nice.
- Forums
- ASX - By Stock
- AN1
- China deal..... Fukang Ren?
China deal..... Fukang Ren?, page-17
-
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online